Medicine and Dentistry
Rheumatoid Arthritis
61%
Inflammatory Arthritis
61%
Methotrexate
32%
Magnetic Resonance Imaging
28%
Cyclosporine
24%
Betamethasone
20%
Glucocorticoid
18%
Randomized Controlled Trial
16%
Synovitis
16%
Edema
11%
Disease Activity
11%
Osteolysis
10%
Adalimumab
10%
Placebo
10%
Combination Therapy
9%
Anti-Citrullinated Protein Antibody
7%
Spontaneous Remission
7%
Bone Density
7%
Monotherapy
7%
Tenosynovitis
6%
Disease
6%
Immunoglobulin M
6%
Bone Erosion
6%
Osteitis
6%
Rheumatoid Factor
6%
Disease-Modifying Antirheumatic Drug
5%
Alopecia Mucinosa
5%
Intra-Articular Injection
5%
Tofacitinib
5%
Cartilage Oligomeric Matrix Protein
5%
Physical Disease
5%
Post-Hoc Analysis
5%
Alendronic Acid
5%
Placebo-Controlled Study
5%
Furylfuramide
5%
Disease Modifying Antirheumatic Drug
5%
Immunology and Microbiology
Inflammatory Arthritis
100%
Methotrexate
21%
Synovitis
21%
Circadian Rhythm
20%
Magnetic Resonance Imaging
17%
Surfactant Protein D
16%
Blood Plasma
15%
Normal Human
12%
Adalimumab
12%
Rheumatoid Factor
11%
Exercise
11%
Physical Activity
11%
Galectin 3
10%
Interleukin 6
10%
Vasculotropin
10%
Anti-Citrullinated Protein Antibody
10%
Cartilage
10%
Immunology
9%
Disease-Modifying Antirheumatic Drug
9%
Immunoglobulin M
7%
Ciclosporin
7%
Arthropathy
6%
Glucocorticoid
6%
Blood Level
6%
Metabolite
5%
Connective Tissue
5%
Tenosynovitis
5%
Osteitis
5%
Seropositivity
5%
Hand Bone
5%
Cell Surface
5%
Mannose Binding Lectin
5%
C-C Chemokine Receptor Type 7
5%
Macrophage Inflammatory Protein 3beta
5%
Epitope
5%
Systemic Inflammation
5%
Tofacitinib
5%
Matrix Protein
5%
DNA Polymorphism
5%
Osteolysis
5%
Pharmacology, Toxicology and Pharmaceutical Science
Inflammatory Arthritis
61%
Rheumatoid Arthritis
61%
Methotrexate
27%
Remission
23%
Ciclosporin
14%
Randomized Controlled Trial
14%
Adalimumab
12%
Glucocorticoid
12%
Edema
11%
Surfactant Protein D
10%
Cyclic Citrullinated Peptide Antibody
9%
Disease
9%
Synovitis
9%
Combination Therapy
9%
Disease Activity
9%
Disease Activity Score
8%
Biological Marker
8%
Placebo
8%
Betamethasone
7%
Monotherapy
7%
Inflammation
6%
Tofacitinib
5%
Alopecia
5%
Interleukin 6
5%
Bone Lesion
5%
Furylfuramide
5%
Vasculotropin
5%
Procollagen
5%
Chitinase 3 Like Protein 1
5%
Galectin 3
5%
Fibrosis
5%
Cartilage Oligomeric Matrix Protein
5%
Placebo-Controlled Study
5%
